Assessing the Multimodal Management of Advanced Solitary Fibrous Tumors of the Pleura in a Routine Practice Setting Olivier Bylicki, Damien Rouvière, Philippe Cassier, Lara Chalabreysse, Alice Levard, Jean-Michel Maury, Jacques Margery, Jean-Yves Blay, Julien Mazières, Nicolas Girard, MD Journal of Thoracic Oncology Volume 10, Issue 2, Pages 309-315 (February 2015) DOI: 10.1097/JTO.0000000000000401 Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 1 First-intent treatment and recurrences according to the De Perrot stage. S, surgery; C, chemotherapy; R, radiotherapy. Journal of Thoracic Oncology 2015 10, 309-315DOI: (10.1097/JTO.0000000000000401) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 2 First-intent chemotherapy: intent of the treatment, regimen, and response. Doxo, doxorubine; MAID, mesna, doxorubicine, ifosfamide, and dacarbazine; CDDP–PEM, cisplatine and pemetrexed; PD, progressive disease; SD, stable disease; CR, complete response (indicates the absence of residual tumor after surgery). Journal of Thoracic Oncology 2015 10, 309-315DOI: (10.1097/JTO.0000000000000401) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 3 Relapse-free survival after first-intent surgery, according to the De Perrot stage. Journal of Thoracic Oncology 2015 10, 309-315DOI: (10.1097/JTO.0000000000000401) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions
FIGURE 4 Treatment of first recurrence. Post-op CT, postoperative chemotherapy; CT, chemotherapy. Journal of Thoracic Oncology 2015 10, 309-315DOI: (10.1097/JTO.0000000000000401) Copyright © 2015 International Association for the Study of Lung Cancer Terms and Conditions